Aspirin as a Pre-Treatment for Exercise in Multiple Sclerosis

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 13, 2017

Primary Completion Date

May 10, 2017

Study Completion Date

May 10, 2017

Conditions
FatigueOverheating
Interventions
DRUG

Acetylsalicylic acid at 1st visit, then Placebo at 2nd visit

650 mg dose of acetylsalicylic acid is administered in a capsule one hour prior to exercise; Placebo oral capsule is administered one hour prior to exercise

DRUG

Placebo at 1st visit, then Acetylsalicylic acid at 2nd visit

Placebo oral capsule is administered one hour prior to exercise; 650 mg dose of acetylsalicylic acid is administered in a capsule one hour prior to exercise

Trial Locations (1)

10032

Columbia University Medical Center, MS Center, New York

All Listed Sponsors
collaborator

National Multiple Sclerosis Society

OTHER

lead

Columbia University

OTHER

NCT03051646 - Aspirin as a Pre-Treatment for Exercise in Multiple Sclerosis | Biotech Hunter | Biotech Hunter